Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Serum neutrophil gelatinase-associated lipocalin - a sensitive novel marker of renal impairment in liver cirrhosis?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genetic and environmental factors in monozygotic twins with Crohn's disease and their first-degree relatives: a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. NOD2/CARD15 Gene Polymorphisms in Crohn's Disease: A Genotype-Phenotype Analysis in Danish and Portuguese Patients and Controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sweet's syndrome--an extraintestinal manifestation in inflammatory bowel disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Gastrointestinal dysfunction in a community sample of subjects with symptoms of irritable bowel syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Aneta Aleksandra Nielsen
  • Jens Nederby Nielsen
  • Henning Grønbaek
  • Martin Eivindson
  • Ida Vind
  • Pia Munkholm
  • Ivan Brandslund
  • Henrik Hey
Vis graf over relationer
BACKGROUND: Patients with Crohn's disease (CD) often develop malnutrition due to disease activity. We aimed to assess the effect of two different enteral supplements of Impact(R) Powder (IP; Novartis, Switzerland) on leptin levels and nutritional status in active CD patients during prednisolone treatment and tapering. METHODS: Thirty-one CD patients were randomized to IP Extra (group 1) or IP Standard (group 2). Leptin levels, nutritional, clinical and biochemical markers were studied at inclusion, after 5 and after 9 weeks of the study. RESULTS: Leptin levels, body mass index (BMI) and total cholesterol increased significantly within both groups at week 5 compared to inclusion. Leptin levels correlated with BMI in both groups at inclusion and in group 2 at week 9. In group 1, triglyceride levels remained unchanged, while levels in group 2 increased significantly at week 5 compared to inclusion. Clinical and biochemical markers improved during the study compared to inclusion. CONCLUSIONS: Increased leptin levels during the study progress were transient, decreasing due to prednisolone withdrawal at the end of the study. Both formulas used as adjuvant therapy to prednisolone treatment were able to improve nutritional status in CD patients.
Udgivelsesdato: 2007-null
OriginalsprogEngelsk
TidsskriftDigestion
Vol/bind75
Udgave nummer1
Sider (fra-til)10-6
Antal sider6
DOI
StatusUdgivet - 2007

Bibliografisk note

Copyright 2007 S. Karger AG, Basel.

ID: 32543040